Clinical Trials

5 enrolled

Breast Neoplasms

NCT04460807 2024-02-12

EXPERT

23 enrolled

Gynecologic

Ovarian Neoplasms

NCT04869943 2024-01-26

ARTEST

52 enrolled

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01303679 2023-09-06

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

117 enrolled

First Line Metastatic Breast Cancer

NCT02990845 2023-02-22

PEER

16 enrolled

Premenopausal Breast Cancer

NCT03874325 2022-05-31

Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer

17 enrolled 10 charts

Breast Neoplasms

NCT03220178 2022-01-06

PRECYCLE

Phase 4 Terminated

532 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00905021 2020-07-24

EXTENT

4 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01627067 2020-06-19

Exemestane-RAD001-Metformin

23 enrolled 7 charts

Breast Neoplasms

NCT01484041 2018-02-09

Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

12 enrolled 7 charts

Breast Neoplasms

NCT00684216 2017-09-14

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Phase 2/3 Terminated

10 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00194792 2017-07-11

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

28 enrolled 9 charts

Breast Neoplasms

NCT01149356 2015-05-25

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Phase 1 Terminated

15 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT01121549 2014-01-22

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

378 enrolled 16 charts

Invasive Early Breast Cancer

NCT00776659 2013-11-19

An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin

39 enrolled 7 charts

Breast Neoplasms

NCT00674557 2013-07-10

Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer

111 enrolled

Breast Neoplasms

NCT00793546 2012-11-05

Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer

42 enrolled 7 charts

Breast Neoplasms

NCT01239745 2012-10-31

Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

46 enrolled 9 charts

Breast Neoplasms

NCT01155063 2012-10-01

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

89 enrolled 12 charts

Breast Neoplasms

NCT01305239 2012-04-10

ETAPE

398 enrolled 10 charts

Breast Neoplasms

NCT00040014 2012-02-16

Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

100 enrolled

Breast Neoplasms

NCT00417885 2010-09-21

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

6 enrolled 6 charts

Breast Neoplasms

NCT00810706 2008-12-18

ATENA

448 enrolled